Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity - Sam, Johannes; Colombetti, Sara; Fauti, Tanja; Roller, Andreas; Biehl, Marlene; Fahrni, Linda; Nicolini, Valeria; Perro, Mario; Nayak, Tapan; Bommer, Esther; Schoenle, Anne; Karagianni, Maria; et al. (Frontiers in Oncology, 2021)